ACS Combinatorial Science
Letter
HPLC analysis (see Supporting Information). The stereochemistry
at 5-position of six membered ring was also confirmed by NMR
and NOESY spectroscopic analysis (see Supporting Information).
In compound 10d, (Figure 3) the location of all protons were
AUTHOR INFORMATION
■
Corresponding Author
* Tel: 91-522-2612411-18, Ext. 4385, 4603. Fax: 91-522-
ACKNOWLEDGMENTS
■
This research project was supported by Department of Science
and Technology, New Delhi, India. Saurav thanks CSIR for
providing fellowship (NET-SRF) and Mr. Purushottam for
HPLC analysis. For Instrumental facilities from SAIF, CDRI
(communication no 8167), Lucknow is acknowledged.
REFERENCES
■
(1) Bates, R.; Sa-Ei, K. Syntheses of the sedum and related alkaloids.
Tetrahedron 2002, 58, 5957.
Figure 3. Confirmation of stereochemistry of 10d by NOESY (400
MHz, CDCl3).
(2) (a) Bailey, P. D.; Millwood, P. A.; Smith, P. D. Asymmetric routes
to substituted piperidines. Chem. Commun. 1998, 633. (b) Laschat, S.;
Dickner, T. Stereoselective synthesis of piperidines. Synthesis 2000,
1781.
(3) (a) Clarke, P. A.; Santos, S. Strategies for the formation of
tetrahydropyran rings in the synthesis of natural products. Eur. J. Org.
Chem. 2006, 2045−2053. (b) Larrosa, I.; Romea, P.; Urpi, F. Synthesis
of six-membered oxygenated heterocycles through carbon-oxygen
bond-forming reactions. Tetrahedron 2008, 64, 2683.
(4) (a) Enders, D.; Meyer, O.; Raabe, G.; Runsink, J. (S,S)-3,5-
dimethylmorpholine, a novel C2-symmetric auxiliary. First application
in [4 + 2]-cycloadditions leading to 4-oxohexahydropyridazine
derivatives. Synthesis 1994, 66−72. (b) Dave, R.; Sasaki, N. A. Facile
route to 3,5-disubstituted morpholines: enantioselective synthesis of
O-protected trans-3,5-bis(hydroxymethyl)morpholines. Org. Lett.
2004, 6, 15−18.
(5) Hajos, M.; Fleishaker, J. C.; Filipiak-Reisner, J. K.; Brown, M. T.;
Wong, E. H. F. The selective norepinephrine reuptake inhibitor
antidepressant reboxetine: pharmacological and clinical profile. CNS
Drug Rev. 2004, 10, 23−44.
(6) Dieckmann, H.; Stockmaier, M.; Kreuzig, R.; Bahadir, M.
Simultaneous determination of fenpropimorph and the corresponding
metabolite fenpropimorphic acid in soil. Fresenius’ J. Anal. Chem. 1993,
345, 784.
(7) Lu, S.; Zhang, Y.; Liu, J.; Zhao, C.; Liu, W.; Xi, R. Preparation of
anti-pefloxacin antibody and development of an indirect competitive
enzyme-linked immunosorbent assay for detection of pefloxacin
residue in chicken liver. J. Agric. Food. Chem. 2006, 54, 6995−7000.
(8) Leopoldo, M.; Lacitiva, E.; Colabufo, N. A.; Contino, M.; Berardi,
F.; Perrone, R. First structure−activity relationship study on dopamine
D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]carboxamide
structure. J. Med. Chem. 2005, 48, 7919−7922.
(9) Askin, D.; Eng, K. K.; Rossen, K.; Purick, R. M.; Welss, K. M.;
Volante, R. P.; Reider, P. J. Highly diastereoselective reaction of a
chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis
of the orally active HIV-1 protease inhibitor L-735,524. Tetrahedron
Lett. 1994, 35, 673−676.
(10) Su, J.; Tang, H.; McKittrick, B. A.; Burnett, D. A.; Zang, H.;
Smith-Torhan, A.; Fawzi, A.; Lachowicz, J. Modification of the
clozapine structure by parallel synthesis. Bioorg. Med. Chem. Lett. 2006,
16, 4548−4553.
confirmed on the basis of the DEPT, HSQC and COSY spectra.
The H-5 showed NOESY correlation with H-3, which is syn to
H-2′, whereas H-2 showed NOESY correlation with H-6, which is
syn to H-5′.
The trans-stereoselectivity of the iodocyclization reactions of
heterosubstituted amino acids derived allylamines 5a−e, 9a−e,
and 12b,c can be explained on the basis of the expected confor-
mational preferences in the proposed transition state of the
reaction (Figure 2). The reaction does not follow “path b” giving
rise to seven-membered rings, and selects the trans isomer of the
6-membered ring. A chairlike transition state exposes the iodo-
methyl group to 1,3-diaxial interactions for the cis isomer but not
for the trans isomer, giving rise to considerably more steric
crowding in the former case.
In summary, we have described a simple and powerful
synthetic route that provides access to diastereoselective 2,5-
disubstituted diverse morpholines, piperazines and thiomorpho-
line starting from commercially available S-amino acids derived
synthetic intermediates. The key step involves iodine mediated
cyclization under mild reaction condition, giving heterocycles that
can be further elaborated in several ways, such as by nucleophilic
substitution on the rings as well as incorporation of substituent at
5-position from amino acids constituents.
EXPERIMENTAL PROCEDURES
■
General Experimental Procedure for the Synthesis of
6a−e. To a stirred solution of compound 5a−e (1 equiv) in
anhydrous THF (10 mL), I2 (1 equiv) was added at 60 °C. Then
it was continuously stirred for 1 h. The reaction mixture was
quenched by addition of sodium thiosulfite and diluted with water
(10 mL). The aqueous layer was extracted with ethyl acetate (3 ×
50 mL), and the organic layer was dried over anhydrous Na2SO4.
After concentration under vacuum, the crude product was chro-
matographed on silica gel with as eluent (hexane/ethyl acetate,
9.5/0.5) to furnish the disubstituted morpholine 6a−e (75−80%
yield) as a colorless oil.
(11) (a) Sun, G.; Savle, P. S.; Gandour, R. D.; Bhaírd, N. N. a;
Ramsay, R. R.; Fronczek, F. R. Syntheses, structures, and enzymic
evaluations of conformationally constrained, analog inhibitors of
carnitine acetyltransferase: (2R,6R)-, (2S,6S)-, (2R,6S)-, and (2S,6R)-
6-(carboxylatomethyl)-2-(hydroxymethyl)-2,4,4-trimethylmorpholinium.
J. Org. Chem. 1995, 60, 6688−6695. (b) Take, K.; Konishi, N.;
Shigenaga, S.; Kayakiri, N.; Azami, H.; Eikyu, Y.; Nakai, K.; Ishida, J.;
Morita, M. Preparation of piperazines for treating or preventing
tachykinin-mediated diseases. PCT Int. Appl. WO 00035915, Jun 22,
2000.
ASSOCIATED CONTENT
■
S
* Supporting Information
Detailed experimental procedures and compound character-
ization data for products. This information is available free of
3
dx.doi.org/10.1021/co200129t | ACS Comb. Sci. 2012, 14, 1−4